selegiline has been researched along with ascorbic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Amjad, MW; Bukhari, SN; Jantan, I; Mahajan, DT; Masand, VH; Naeem-ul-Hassan, M; Sher, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fahn, S; Jackson-Lewis, V; Przedborski, S | 1 |
| Chiueh, CC; Huang, SJ; Murphy, DL | 1 |
| Fahn, S; García de Yébenes, J; Mena, MA; Pardo, B | 1 |
| Cohen, G; Han, SK; Heinonen, EH; Leonardi, EK; Mytilineou, C; Olanow, CW; Radcliffe, P; Werner, P | 1 |
| Mertz, K; Morgan, JI; Schmidt, J | 1 |
| Acuña-Castroviejo, D; Escames, G; Khaldy, H; León, J; Luna, JD; Vives, F | 1 |
| Delanty, N; Praticò, D | 1 |
| Andreazza, AC; Berk, M; Dean, O; Kapczinski, F; Magalhães, PV | 1 |
3 review(s) available for selegiline and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Antioxidants; Ascorbic Acid; Benzoquinones; Central Nervous System; Central Nervous System Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Free Radicals; Ginkgo biloba; Humans; Lipid Peroxidation; Neuroprotective Agents; Oxidation-Reduction; Phytotherapy; Plants, Medicinal; Selegiline; Ubiquinone; Vitamin E | 2000 |
Antioxidant treatments for schizophrenia.
Topics: Acetylcysteine; Allopurinol; Antioxidants; Antipsychotic Agents; Ascorbic Acid; Dehydroepiandrosterone; Drug Therapy, Combination; Free Radical Scavengers; Ginkgo biloba; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Schizophrenia; Selegiline; Vitamin E; Vitamins | 2016 |
9 other study(ies) available for selegiline and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloid β-induced cytotoxicity.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Catalytic Domain; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Green Chemistry Technology; Inhibitory Concentration 50; Ketones; Molecular Docking Simulation; Neuroprotective Agents; PC12 Cells; Quantitative Structure-Activity Relationship; Rats | 2014 |
Antiparkinsonian therapies and brain mitochondrial complex I activity.
Topics: Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Ascorbic Acid; Brain; Cholinergic Antagonists; Dopamine; Dose-Response Relationship, Drug; Levodopa; Male; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley; Selegiline | 1995 |
Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity.
Topics: Ascorbic Acid; Clorgyline; Dopamine; Dopamine Agents; Dopamine Antagonists; Hydroxyl Radical; Melanins; Monoamine Oxidase Inhibitors; Nervous System; Oxidation-Reduction; Pargyline; Selegiline | 1994 |
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line.
Topics: Ascorbic Acid; Brain; Brain Neoplasms; Catecholamines; Cell Line; Drug Interactions; Female; Humans; Levodopa; Male; Neuroblastoma; Parkinson Disease; Quinones; Selegiline | 1993 |
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.
Topics: Amphetamines; Animals; Ascorbic Acid; Buthionine Sulfoximine; Cells, Cultured; Dose-Response Relationship, Drug; Glutathione; Mazindol; Mesencephalon; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Pargyline; Rats; Selegiline; Tyrosine 3-Monooxygenase | 1998 |
Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Astrocytes; Catechol O-Methyltransferase Inhibitors; Catechols; Cell Line; Cycloheximide; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glioma; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hemin; Membrane Proteins; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; RNA, Messenger; Selegiline; Time Factors; Tumor Cells, Cultured | 1999 |
Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro.
Topics: Antioxidants; Ascorbic Acid; Chromans; Dopamine; Dose-Response Relationship, Drug; Hydroxybenzoates; Hydroxyl Radical; Iron; Melatonin; Oxidation-Reduction; Salicylates; Selegiline | 2000 |